LOPID (Gemfibrozil Tablets, USP)
ثبت نشده
چکیده
DESCRIPTION LOPID (gemfibrozil tablets, USP) is a lipid regulating agent. It is available as tablets for oral administration. Each tablet contains 600 mg gemfibrozil. Each tablet also contains calcium stearate, NF; candelilla wax, FCC; microcrystalline cellulose, NF; hydroxypropyl cellulose, NF; hypromellose, USP; methylparaben, NF; Opaspray white; polyethylene glycol, NF; polysorbate 80, NF; propylparaben, NF; colloidal silicon dioxide, NF; pregelatinized starch, NF. The chemical name is 5-(2,5-dimethylphenoxy) 2,2-dimethylpentanoic acid, with the following structural formula:
منابع مشابه
Comparison of Gemfibrozil and Lopid Effects on Reduction of Serum Levels of Triglyceride and Cholesterol in Hyperlipedimic Patients
Introduction: Hyperlipidemia is one of the most important and common risk factors of cardiovascular diseases especially Atherosclerosis and consequently CHD. Unalike age and gender, hyperlipidemia is a factor which can be controlled by altering the life style, nutritional habits and medical-medicinal interventions. Although serum level of cholesterol is always noticed in hyperlipidemia, hypertr...
متن کاملComparison of Gemfibrozil and Lopid Effects on Reduction of Serum Levels of Triglyceride and Cholesterol in Hyperlipedimic Patients
Introduction: Hyperlipidemia is one of the most important and common risk factors of cardiovascular diseases especially Atherosclerosis and consequently CHD. Unalike age and gender, hyperlipidemia is a factor which can be controlled by altering the life style, nutritional habits and medical-medicinal interventions. Although serum level of cholesterol is always noticed in hyperlipidemia, hypertr...
متن کاملProgression of Atherosclerosis Is Associated With Variation in the 1-Antitrypsin Gene
Objective— 1-Antitrypsin (AAT) protects elastic tissue and may play a role in atherogenesis. The association of atherosclerosis progression with common AAT variants was considered in 2 clinical trials. Methods and Results—We examined the association of AAT V213A, S and Z deficiency alleles, and the functional 3 UTR 11478G A with change in minimal luminal diameter, a measure of focal disease, in...
متن کاملAPOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study.
Animal and human studies support a role for apolipoprotein A-V (apoA-V) in triglyceride (TG) metabolism. We examined the relationship of APOA5 -1131T>C and S19W with lipid subfractions and progression of atherosclerosis in the Lopid Coronary Angiography Trial. Compared with -1131TT men (n = 242), carriers of the -1131C allele (n = 54) had significantly higher total TG (P = 0.03), reflected in s...
متن کاملProgression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene.
OBJECTIVE Alpha1-Antitrypsin (AAT) protects elastic tissue and may play a role in atherogenesis. The association of atherosclerosis progression with common AAT variants was considered in 2 clinical trials. METHODS AND RESULTS We examined the association of AAT V213A, S and Z deficiency alleles, and the functional 3' UTR 11478G>A with change in minimal luminal diameter, a measure of focal dise...
متن کامل